HTEC — ROBO Global(R) Healthcare Technology and Innovation ETF
Data updated: 2026-07-07
HTEC — ROBO Global(R) Healthcare Technology and Innovation ETF data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $53.34M AUM · 0.68% expense ratio · 24.4% 1-yr return. From SEC regulatory filings.
HTEC Fund Overview
HTEC — ROBO Global(R) Healthcare Technology and Innovation ETF is a US ETF managed by Exchange Traded Concepts Trust, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Exchange Traded Concepts Trust
- Category: United States Health Care Equity
- Assets under management: $53.34M
- 1-year return: 24.4%
- Ticker: HTEC
- SEC CIK: 0001452937
- SEC series ID: S000065730
- Share class ID: C000212575
HTEC Holdings
Top 10 holdings of ROBO Global(R) Healthcare Technology and Innovation ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| AxoGen, Inc. | 3.16% |
| Arrowhead Pharmaceuticals, Inc. | 2.56% |
| Twist Bioscience Corp | 2.34% |
| Glaukos Corporation | 2.22% |
| Natera, Inc. | 2.17% |
| Tempus Ai, Inc. | 2.13% |
| Novocure Limited | 2.04% |
| Alnylam Pharmaceuticals, Inc. | 2.01% |
| Guardant Health, Inc. | 1.99% |
| Thermo Fisher Scientific Incorporated | 1.99% |
HTEC Portfolio Allocation
Asset-class allocation of ROBO Global(R) Healthcare Technology and Innovation ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.7% |
| Cash & Equivalents | 0.3% |
HTEC Performance
Total returns for HTEC (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -1.9% |
| 1 year | 24.4% |
| 3 years (annualised) | 3.6% |
| 5 years (annualised) | -6.2% |
HTEC Risk Information
Risk metrics for HTEC, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 17.6%
HTEC Costs and Fees
HTEC costs about $68 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.68%
- Gross expense ratio: 0.80%
- Portfolio turnover: 35%
- Brokerage commissions: 1.79 bps of average net assets (SEC N-CEN)
HTEC Cashflows
Over the 12 months to 2026-04, ROBO Global(R) Healthcare Technology and Innovation ETF had net inflows of $3.53M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | $0 |
| 2026-03 | $0 |
| 2026-02 | $3.27M |
| 2026-01 | $0 |
| 2025-12 | $0 |
| 2025-11 | $0 |
HTEC Debt Constituents
No individual debt constituents are reported in ROBO Global(R) Healthcare Technology and Innovation ETF's latest SEC N-PORT filing.
HTEC Prospectus and SEC Filings
Official ROBO Global(R) Healthcare Technology and Innovation ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.